Fennec Pharmaceuticals Inc (FRX.TO)
8.87
-0.10
(-1.11%)
CAD |
TSX |
Jun 21, 12:37
Fennec Pharmaceuticals Net Income (Quarterly): 17.30M for March 31, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 17.30M |
| December 31, 2023 | -3.651M |
| September 30, 2023 | -2.505M |
| June 30, 2023 | -7.317M |
| March 31, 2023 | -8.188M |
| December 31, 2022 | -9.273M |
| September 30, 2022 | -10.55M |
| June 30, 2022 | -6.467M |
| March 31, 2022 | -4.680M |
| December 31, 2021 | -5.577M |
| September 30, 2021 | -5.269M |
| June 30, 2021 | -4.912M |
| March 31, 2021 | -5.990M |
| December 31, 2020 | -4.218M |
| September 30, 2020 | -8.255M |
| June 30, 2020 | -6.715M |
| March 31, 2020 | -5.133M |
| December 31, 2019 | -4.765M |
| September 30, 2019 | -2.389M |
| June 30, 2019 | -6.328M |
| March 31, 2019 | -3.492M |
| December 31, 2018 | -3.945M |
| September 30, 2018 | -3.594M |
| June 30, 2018 | -3.338M |
| March 31, 2018 | -1.981M |
| Date | Value |
|---|---|
| December 31, 2017 | -2.912M |
| September 30, 2017 | -2.949M |
| June 30, 2017 | -2.150M |
| March 31, 2017 | -1.067M |
| December 31, 2016 | -1.525M |
| September 30, 2016 | -0.6546M |
| June 30, 2016 | -0.9328M |
| March 31, 2016 | -0.5769M |
| December 31, 2015 | -0.7213M |
| September 30, 2015 | -0.1609M |
| June 30, 2015 | -0.2127M |
| March 31, 2015 | 0.2192M |
| December 31, 2014 | 1.578M |
| September 30, 2014 | 0.4137M |
| June 30, 2014 | -0.818M |
| March 31, 2014 | -3.520M |
| December 31, 2013 | 1.166M |
| September 30, 2013 | -1.834M |
| June 30, 2013 | 6.758M |
| March 31, 2013 | -4.139M |
| December 31, 2012 | -6.454M |
| September 30, 2012 | -0.7608M |
| June 30, 2012 | -0.6079M |
| March 31, 2012 | 2.719M |
| December 31, 2011 | 3.591M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-10.55M
Minimum
Sep 2022
17.30M
Maximum
Mar 2024
-4.744M
Average
-5.423M
Median
Net Income (Quarterly) Benchmarks
| Ionic Brands Corp | -1.742M |
| 4Front Ventures Corp | -24.88M |
| Green Thumb Industries Inc | 41.89M |
| Lowell Farms Inc | -3.894M |
| Bright Minds Biosciences Inc | -0.5741M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 34.21M |
| Total Expenses (Quarterly) | 15.71M |
| EPS Diluted (Quarterly) | 0.5527 |
| Enterprise Value | 218.22M |
| Gross Profit Margin (Quarterly) | 97.83% |
| Profit Margin (Quarterly) | 50.59% |
| Earnings Yield | 0.46% |
| Operating Earnings Yield | 3.33% |
| Normalized Earnings Yield | 0.4769 |